(Q43574440)

24 November 2017

Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma (English)

1 reference

24 November 2017

1 reference

J C Cruz

1

1 reference

24 November 2017

M Alsina

2

1 reference

24 November 2017

F Craig

3

1 reference

24 November 2017

T Yoneda

4

1 reference

24 November 2017

J L Anderson

5

1 reference

24 November 2017

M Dallas

6

1 reference

24 November 2017

G D Roodman

7

1 reference

24 November 2017

1 April 2001

1 reference

24 November 2017

Experimental Hematology

1 reference

24 November 2017

29

1 reference

24 November 2017

441-447

1 reference

24 November 2017

4

1 reference

Current use of bisphosphonates in oncology. International Bone and Cancer Study Group

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900618-X

7 January 2021

Management of acute hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900618-X

7 January 2021

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900618-X

7 January 2021

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900618-X

7 January 2021

BM 21.0955, a potent new bisphosphonate to inhibit bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900618-X

7 January 2021

Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900618-X

7 January 2021

Targeting simian virus 40 T antigen to the osteoclast in transgenic mice causes osteoclast tumors and transformation and apoptosis of osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900618-X

7 January 2021

Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900618-X

7 January 2021

Sequential expression of phenotype markers for osteoclasts during differentiation of precursors for multinucleated cells formed in long-term human marrow cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900618-X

7 January 2021

Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900618-X

7 January 2021

Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900618-X

7 January 2021

10.1016/S0301-472X(01)00618-X

Identifiers

DOI

1 reference

24 November 2017

1 reference